直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

Inherency Remains High Bar to Meet

June 21, 2024

Authored and Edited by Adriana L. Burgy; Stacy Lewis†

Inherent anticipation arises when the prior art discloses a property that is “necessarily present.” Arbutus Biopharma Corp. v. Modernatx, Inc., 65 F.4th 656, 662 (Fed. Cir. 2023); Trintec Indus., Inc. v. Top-U.S.A. Corp., 295 F.3d 1292, 1295 (Fed. Cir. 2002). The Federal Circuit has a long-established standard for determining inherency:

Inherency . . . may not be established by probabilities or possibilities. The mere fact that a certain thing may result from a given set of circumstances is not sufficient. If, however, the disclosure is sufficient to show that the natural result flowing from the operation as taught would result in the performance of the questioned function, it seems to be well settled that the disclosure should be regarded as sufficient.

Continental Can Co. USA, Inc. v. Monsanto Co., 948 F.2d 1264, 1267-69 (Fed. Cir. 1991) (quoting In re Oelrich, 666 F.2d 578, 581 (CCPA 1981)).

The Federal Circuit applied that standard in Arbutus v. Modernatx to find inherent anticipation, affirming a holding of unpatentability by the Patent Trial and Appeal Board (“the PTAB”). Making the formulations according to the prior art “would naturally result in a composition having the claimed . . . property.” Arbutus Biopharma Corp. v. Modernatx, Inc., 65 F.4th 656, 664 (Fed. Cir. 2023). This was not “a case where there is only a probability that the Morphology Limitation would result from controlling several variations of formulations and processes.” Id. at 664-665.

In SNF S.A. v. Chevron U.S.A., Inc., IPR2022-01534, Paper 46 (P.T.A.B. Apr. 18, 2024), the PTAB found that the high standard to show inherent anticipation was not met. The challenged independent claim recited a method for preparing an inverted polymer solution, and the limitation at issue was “wherein the inverted polymer solution has a filter ratio of 1.5 or less at 15 psi using a 1.2 μm filter.” According to Petitioner, this feature is an inherent physical property. Id. at *10. To prove it, Petitioner’s experts conducted tests based on the prior art disclosure. Id. at *22. However, as Patent Owner explained, Petitioner’s expert modified the procedure. Id. at *23. When analyzed without the modification, the process did not meet the specific filter ratio. Id. at *27. The PTAB concluded that Petitioner failed to prove inherent anticipation by a preponderance of the evidence. Id. An appeal to the Federal Circuit was filed June 5, 2024.

Take Aways

Inherent anticipation is a high bar. Patent Owners can overcome inherent anticipation arguments by showing that practicing the prior art does not “necessarily and inevitably” result in the claimed invention.

Related Practices

Prosecution and Portfolio Management

Related Industries

Life Sciences

Pharmaceutical

Biotechnology

Related Offices

Washington, DC

Contacts

Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email

†Stacy Lewis is a Law Clerk at Finnegan.

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 



DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Charitable

TopGolf for the Troops 2026

June 11, 2026

Ashburn

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP